Pathology of fatty liver: differential diagnosis of non-alcoholic fatty liver disease

Diagnostic Histopathology

Volumn 14, Issue 12, 2008, Pages 586-597

  Yeh, Matthew M ^a,b   Brunt, Elizabeth M ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

alcoholic liver disease; fatty liver; non alcoholic; steatohepatitis

Indexed keywords

CORTICOSTEROID; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR ANTIBODY;

ALCOHOL LIVER DISEASE; ARTICLE; AUTOIMMUNE DISEASE; DIFFERENTIAL DIAGNOSIS; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; INTERVENTION STUDY; IRON OVERLOAD; LIVER BIOPSY; LIVER HISTOLOGY; LIVER TRANSPLANTATION; NOMENCLATURE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PATHOLOGIST; PEDIATRICS; POPULATION; RECURRENT DISEASE; WILSON DISEASE;

EID: 56249115241     PISSN: 17562317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpdhp.2008.09.005     Document Type: Article

References (95)

1. Panel. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
2. Browning J.D., Szczepaniak L.S., Dobbins R., et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40 (2004) 1387-1395
3. Weston S.R., Leyden W., Murphy R., et al. Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology 41 (2005) 372-379
4. Patton H.M., Sirlin C., Behling C., Middleton M.S., Schwimmer J.B., and Lavine J.E. Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research. J Pediatr Gastroenterol Nutr 43 (2006) 413-427
5. Hossain P., Kawar B., and El Nahas M. Obesity and diabetes in the developing world - a growing challenge. N Engl J Med 356 (2007) 213-215
6. Mandayam S., Jamal M.M., and Morgan T.R. Epidemiology of alcoholic liver disease. Semin Liver Dis 24 (2004) 217-232
7. Farrell G.C., and Larter C.Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43 2 Suppl 1 (2006) S99-S112
8. Brunt E.M., Janney C.G., Di Bisceglie A.M., Neuschwander-Tetri B.A., and Bacon B.R. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94 (1999) 2467-2474
9. Kleiner D.E., Brunt E.M., Van Natta M., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41 (2005) 1313-1321
10. Skelly M.M., James P.D., and Ryder S.D. Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology. J Hepatol 35 (2001) 195-199
11. Merriman R.B., Ferrell L.D., Patti M.G., et al. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Hepatology 44 (2006) 874-880
12. Mofrad P., Contos M.J., Haque M., et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 37 (2003) 1286-1292
13. Brunt E.M. Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond. Hepatology 31 (2000) 241-246
14. Brunt E.M. Liver biopsy interpretation for the gastroenterologist. Curr Gastroenterol Rep 2 (2000) 27-32
15. Ishak K.G. Chronic hepatitis: morphology and nomenclature. Mod Pathol 7 (1994) 690-713
16. Brunt E.M., Ramrakhiani S., Cordes B.G., et al. Concurrence of histologic features of steatohepatitis with other forms of chronic liver disease. Mod Pathol 16 (2003) 49-56
17. Sanyal A.J., Contos M.J., Sterling R.K., et al. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome. Am J Gastroenterol 98 (2003) 2064-2071
18. Levitsky J., and Mailliard M.E. Diagnosis and therapy of alcoholic liver disease. Semin Liver Dis 24 (2004) 233-247
19. Ludwig J., Viggiano T.R., McGill D.B., and Oh B.J. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55 (1980) 434-438
20. Chitturi S., Abeygunasekera S., Farrell G.C., et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 35 (2002) 373-379
21. Marchesini G., Bugianesi E., Forlani G., et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37 (2003) 917-923
22. Burt A.D., Mutton A., and Day C.P. Diagnosis and interpretation of steatosis and steatohepatitis. Semin Diagn Pathol 15 (1998) 246-258
23. Matteoni C.A., Younossi Z.M., Gramlich T., Boparai N., Liu Y.C., and McCullough A.J. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116 (1999) 1413-1419
24. Younossi Z.M., Gramlich T., Liu Y.C., et al. Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations. Mod Pathol 11 (1998) 560-565
25. Brunt E.M., Neuschwander-Tetri B.A., Oliver D., Wehmeier K.R., and Bacon B.R. Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens. Hum Pathol 35 (2004) 1070-1082
26. Brunt E.M. Nonalcoholic steatohepatitis. Semin Liver Dis 24 (2004) 3-20
27. Hui J.M., Sud A., Farrell G.C., et al. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression. [corrected]. Gastroenterology 125 (2003) 1695-1704
28. Kashireddy P.R., and Rao M.S. Sex differences in choline-deficient diet-induced steatohepatitis in mice. Exp Biol Med (Maywood) 229 (2004) 158-162
29. Svegliati-Baroni G., Candelaresi C., Saccomanno S., et al. A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury. Am J Pathol 169 (2006) 846-860
30. Feldstein A.E., Canbay A., Angulo P., et al. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 125 (2003) 437-443
31. Ramalho R.M., Cortez-Pinto H., Castro R.E., et al. Apoptosis and Bcl- 2 expression in the livers of patients with steatohepatitis. Eur J Gastroenterol Hepatol 18 (2006) 21-29
32. Wieckowska A., Zein N.N., Yerian L.M., Lopez A.R., McCullough A.J., and Feldstein A.E. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology 44 (2006) 27-33
33. Younossi Z.M., Gorreta F., Ong J.P., et al. Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis. Liver Int 25 (2005) 760-771
34. Teli M.R., Day C.P., Burt A.D., Bennett M.K., and James O.F. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet 346 (1995) 987-990
35. Fromenty B., Grimbert S., Mansouri A., et al. Hepatic mitochondrial DNA deletion in alcoholics: association with microvesicular steatosis. Gastroenterology 108 (1995) 193-200
36. Pessayre D., Berson A., Fromenty B., and Mansouri A. Mitochondria in steatohepatitis. Semin Liver Dis 21 (2001) 57-69
37. Torbenson M., Chen Y.Y., Brunt E., et al. Glycogenic hepatopathy: an underrecognized hepatic complication of diabetes mellitus. Am J Surg Pathol 30 (2006) 508-513
38. Li M.K., and Crawford J.M. The pathology of cholestasis. Semin Liver Dis 24 (2004) 21-42
39. Caldwell S.H., Swerdlow R.H., Khan E.M., et al. Mitochondrial abnormalities in non-alcoholic steatohepatitis. J Hepatol 31 (1999) 430-434
40. Sanyal A.J., Campbell-Sargent C., Mirshahi F., et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120 (2001) 1183-1192
41. Brunt E.M., Kleiner D.E., Behling C., Wilson L., Lavine J.E., Neuschwander-Tetri B.A., and Nonalcoholic Steatohepatitis Clinical Research Network Group. Portal inflammation in NAFLD: correlations from the NASH CRN database. Presented, AASLD, 2006. Hepatology 44 (2006) 655A
42. Itoh S., Yougel T., and Kawagoe K. Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis. Am J Gastroenterol 82 (1987) 650-654
43. Richardson M.M., Jonsson J.R., Powell E.E., et al. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. Gastroenterology 133 (2007) 80-90
44. Brunt E.M. Alcoholic and nonalcoholic steatohepatitis. Clin Liver Dis 6 (2002) 399-420 vii
45. Weltman M.D., Farrell G.C., Hall P., Ingelman-Sundberg M., and Liddle C. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology 27 (1998) 128-133
46. Weltman M.D., Farrell G.C., and Liddle C. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology 111 (1996) 1645-1653
47. Pinto H.C., Baptista A., Camilo M.E., Valente A., Saragoca A., and de Moura M.C. Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients. Dig Dis Sci 41 (1996) 172-179
48. Thung S.N.G.M. Alcoholic hepatitis vs. nonalcoholic steatohepatitis. In: Thung S.N. (Ed). Differential diagnosis in pathology: liver disorders (1995), Igaku-Shoin, New York 24-26
49. Falck-Ytter Y., Younossi Z.M., Marchesini G., and McCullough A.J. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis 21 (2001) 17-26
50. Schwimmer J.B., Behling C., Newbury R., et al. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology 42 (2005) 641-649
51. Yip W.W., and Burt A.D. Alcoholic liver disease. Semin Diagn Pathol 23 (2006) 149-160
52. Goodman Z.D., and Ishak K.G. Histopathology of hepatitis C virus infection. Semin Liver Dis 15 (1995) 70-81
53. Adinolfi L.E., Gambardella M., Andreana A., Tripodi M.F., Utili R., and Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 33 (2001) 1358-1364
54. Castera L., Hezode C., Roudot-Thoraval F., et al. Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies. Gut 52 (2003) 288-292
55. Monto A., Alonzo J., Watson J.J., Grunfeld C., and Wright T.L. Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol. Hepatology 36 (2002) 729-736
56. Moriya K., Yotsuyanagi H., Shintani Y., et al. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol 78 (1997) 1527-1531
57. Cotler S.J., Kanji K., Keshavarzian A., Jensen D.M., and Jakate S. Prevalence and significance of autoantibodies in patients with non-alcoholic steatohepatitis. J Clin Gastroenterol 38 (2004) 801-804
58. Loria P., Lonardo A., Leonardi F., et al. Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates. Dig Dis Sci 48 (2003) 2173-2181
59. McFarlane I.G. Autoimmune hepatitis: diagnostic criteria, subclassifications, and clinical features. Clin Liver Dis 6 (2002) 605-621
60. Reid A.E. Nonalcoholic steatohepatitis. Gastroenterology 121 (2001) 710-723
61. Bonkovsky H.L., Jawaid Q., Tortorelli K., et al. Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis. J Hepatol 31 (1999) 421-429
62. Bugianesi E., Manzini P., D'Antico S., et al. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver. Hepatology 39 (2004) 179-187
63. Zelber-Sagi S., Nitzan-Kaluski D., Halpern Z., and Oren R. NAFLD and hyperinsulinemia are major determinants of serum ferritin levels. J Hepatol 46 (2007) 700-707
64. Ong J.P., Younossi Z.M., Speer C., Olano A., Gramlich T., and Boparai N. Chronic hepatitis C and superimposed nonalcoholic fatty liver disease. Liver 21 (2001) 266-271
65. Franzese A., Vajro P., Argenziano A., et al. Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig Dis Sci 42 (1997) 1428-1432
66. Mager D.R., and Roberts E.A. Nonalcoholic fatty liver disease in children. Clin Liver Dis 10 (2006) 109-131 vi-vii
67. Nobili V., Marcellini M., Devito R., et al. NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice. Hepatology 44 (2006) 458-465
68. Hedley A.A., Ogden C.L., Johnson C.L., Carroll M.D., Curtin L.R., and Flegal K.M. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 291 (2004) 2847-2850
69. Schwimmer J.B., Deutsch R., Rauch J.B., Behling C., Newbury R., and Lavine J.E. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr 143 (2003) 500-505
70. Moran J.R., Ghishan F.K., Halter S.A., and Greene H.L. Steatohepatitis in obese children: a cause of chronic liver dysfunction. Am J Gastroenterol 78 (1983) 374-377
71. Baldridge A.D., Perez-Atayde A.R., Graeme-Cook F., Higgins L., and Lavine J.E. Idiopathic steatohepatitis in childhood: a multicenter retrospective study. J Pediatr 127 (1995) 700-704
72. Manton N.D., Lipsett J., Moore D.J., Davidson G.P., Bourne A.J., and Couper R.T. Non-alcoholic steatohepatitis in children and adolescents. Med J Aust 173 (2000) 476-479
73. Lindor K.D., Kowdley K.V., Heathcote E.J., et al. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial. Hepatology 39 (2004) 770-778
74. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 346 (2002) 1221-1231
75. Neuschwander-Tetri B.A., Brunt E.M., Wehmeier K.R., Oliver D., and Bacon B.R. Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone. Hepatology 38 (2003) 1008-1017
76. Brunt E.M. Nonalcoholic steatohepatitis: pathologic features and differential diagnosis. Semin Diagn Pathol 22 (2005) 330-338
77. Promrat K., Lutchman G., Uwaifo G.I., et al. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatology 39 (2004) 188-196
78. Huang M.A., Greenson J.K., Chao C., et al. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study. Am J Gastroenterol 100 (2005) 1072-1081
79. Lutchman G., Modi A., Kleiner D.E., et al. The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis. Hepatology 46 (2007) 424-429
80. Dixon J.B., Bhathal P.S., Hughes N.R., and O'Brien P.E. Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology 39 (2004) 1647-1654
81. Brunt E.M., and Clouston A.D. Histologic features of fatty liver disease. In: Bataller R. (Ed). International hepatology updates: nonalcoholic steatohepatitis (2007), Permanyer Press, Barcelona 95-110
82. Leevy C.M. Fatty liver: a study of 270 patients with biopsy proven fatty liver and review of the literature. Medicine (Balt) 41 (1962) 249-276
83. Galambos J.T. Natural history of alcoholic hepatitis. 3. Histological changes. Gastroenterology 63 (1972) 1026-1035
84. Czaja A.J. Recurrence of nonalcoholic steatohepatitis after liver transplantation. Liver Transpl Surg 3 (1997) 185-186
85. Molloy R.M., Komorowski R., and Varma R.R. Recurrent nonalcoholic steatohepatitis and cirrhosis after liver transplantation. Liver Transpl Surg 3 (1997) 177-178
86. Carson K., Washington M.K., Treem W.R., Clavien P.A., and Hunt C.M. Recurrence of nonalcoholic steatohepatitis in a liver transplant recipient. Liver Transpl Surg 3 (1997) 174-176
87. Kim W.R., Poterucha J.J., Porayko M.K., Dickson E.R., Steers J.L., and Wiesner R.H. Recurrence of nonalcoholic steatohepatitis following liver transplantation. Transplantation 62 (1996) 1802-1805
88. Contos M.J., Cales W., Sterling R.K., et al. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis. Liver Transpl 7 (2001) 363-373
89. Neuschwander-Tetri B.A., and Caldwell S.H. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 37 (2003) 1202-1219
90. Watt K.D., and McCashland T.M. Transplantation in the alcoholic patient. Semin Liver Dis 24 (2004) 249-255
91. Burra P., Mioni D., Cecchetto A., et al. Histological features after liver transplantation in alcoholic cirrhotics. J Hepatol 34 (2001) 716-722
92. Everson G., Bharadhwaj G., House R., et al. Long-term follow-up of patients with alcoholic liver disease who underwent hepatic transplantation. Liver Transpl Surg 3 (1997) 263-274
93. Pageaux G.P., Bismuth M., Perney P., et al. Alcohol relapse after liver transplantation for alcoholic liver disease: does it matter?. J Hepatol 38 (2003) 629-634
94. Conjeevaram H.S., Hart J., Lissoos T.W., et al. Rapidly progressive liver injury and fatal alcoholic hepatitis occurring after liver transplantation in alcoholic patients. Transplantation 67 (1999) 1562-1568
95. Savolainen V., Perola M., Lalu K., Penttila A., Virtanen I., and Karhunen P.J. Early perivenular fibrogenesis - precirrhotic lesions among moderate alcohol consumers and chronic alcoholics. J Hepatol 23 (1995) 524-531